Fecal microbiota transplantation: Facts and controversies

Current Opinion in Gastroenterology

Volumn 30, Issue 1, 2014, Pages 34-39

  Van Nood, Els ^a,b   Speelman, Peter ^a,b   Nieuwdorp, Max ^a,b   Keller, Josbert ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

Clostridium difficile; donor feces infusion; fecal microbiota transplantation; inflammatory bowel syndrome; metabolic syndrome

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BLEEDING; CLOSTRIDIUM DIFFICILE INFECTION; COLON FLORA; COLON PERFORATION; CROHN DISEASE; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; HUMAN; METABOLIC SYNDROME X; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; TRANSPLANTATION; ULCERATIVE COLITIS; VOMITING;

CLINICAL PROTOCOLS; DONOR SELECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; METABOLIC SYNDROME X; MICROBIOTA; RECURRENCE; TISSUE TRANSPLANTATION;

EID: 84890435364     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000024     Document Type: Review

References (33)

1. Zhang F, Luo W, Shi Y, et al. Should we standardize the 1700-year-old fecal microbiota transplantation Am J Gastroenterol 2012; 107:1755-1756.
2. Merde LRA. Excursions in scientific, cultural, and socio-historical coprology. New York: Random House Inc.; 1999.
3. Eiseman B, Silen W, BascomGS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44:854-859.
4. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994-1002.
5. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9:1044-1049.
6. Van Nood E, Speelman P, Kuijper EJ, Keller JJ. Struggling with recurrent Clostridium difficile infections: Is donor faeces the solution Euro Surveill 2009; 14:19316.
7. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 (Suppl 6):2-18.
8. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355-1359.
9. Zoetendal EG, Vaughan EE, de Vos WM. A microbial world within us. Mol Microbiol 2006; 59:1639-1650.
10. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009; 98:229-238.
11. Vrieze A, de Groot PF, Kootte RS, et al. Fecal transplant: A safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease Best Pract Res Clin Gastroenterol 2013; 27:127-137.
12. Perez-Cobas AE, Gosalbes MJ, Friedrichs A, et al. Gut microbiota disturbance during antibiotic therapy: A multiomic approach. Gut 2013; 62:1591-1601.
13. Viau E, Peccia J. Survey of wastewater indicators and human pathogen genomes in biosolids produced by class A and class B stabilization treatments. Appl Environ Microbiol 2009; 75:164-174.
14. Rousseau C, Poilane I, De PL, et al. Clostridium difficile carriage in healthy infants in the community: A potential reservoir for pathogenic strains. Clin Infect Dis 2012; 55:1209-1215.
15. Miyajima F, Roberts P, Swale A, et al. Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 2011; 6:; e22804.
16. Kelly CP, LaMont JT. Clostridium difficile: More difficult than ever. N Engl J Med 2008; 359:1932-1940.
17. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197:435-438.
18. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44:354-360.
19. Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-415. The first randomized trial in which FMT is given for recurrent CDI.
20. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107:761-767.
21. You DM, Franzos MA, Holman RP. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med 2008; 148:632-633.
22. Knaapen M, Kootte RS, Zoetendal EG, et al. Obesity, nonalcoholic fatty liver disease, and atherothrombosis: A role for the intestinal microbiota Clin Microbiol Infect 2013; 19:331-337.
23. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-1031.
24. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101:15718-15723.
25. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913-916. A trial in which feces of lean men is given to obese healthy volunteers, leading to increased insulin sensitivity.
26. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; 1:164.
27. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37:42-47.
28. Kunde S, Pham A, Bonczyk S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56:597-601.
29. Vermeire S, Joossens M, Verbeke K, Hildebrand F, et al. Sa1922 pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn's disease. Gastroenterology 2012; 142 (5 Suppl 1):S-360.
30. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012; 9:88-96.
31. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15:285-289.
32. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1:1156-1160.
33. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we Inflamm Bowel Dis 2012; 18:676-684.